0001209191-20-062936.txt : 20201211 0001209191-20-062936.hdr.sgml : 20201211 20201211162010 ACCESSION NUMBER: 0001209191-20-062936 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas John C CENTRAL INDEX KEY: 0001424620 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37507 FILM NUMBER: 201383782 MAIL ADDRESS: STREET 1: 8601 SIX FORKS ROAD, SUITE 160 CITY: RALEIGH STATE: NC ZIP: 27615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NantKwest, Inc. CENTRAL INDEX KEY: 0001326110 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 431979754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3530 JOHN HOPKINS COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 633-0300 MAIL ADDRESS: STREET 1: 3530 JOHN HOPKINS COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Conkwest, Inc. DATE OF NAME CHANGE: 20140416 FORMER COMPANY: FORMER CONFORMED NAME: ZelleRx Corp DATE OF NAME CHANGE: 20050504 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-10 0 0001326110 NantKwest, Inc. NK 0001424620 Thomas John C C/O NANTKWEST, INC. 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 1 0 0 0 Common Stock 2020-12-10 4 S 0 42592 10.8265 D 207477 D Common Stock 13886 I See footnote The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 10, 2020. Represents the weighted average share price of an aggregate total of 42,592 shares sold in the price range of $10.17 to $11.14 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96. /s/ Sonja Nelson, as Attorney-in-Fact 2020-12-11